Skip to main content
Logo for WebMD
  • Home
  • Conditions
    Conditions View All
    • ADD/ADHD
    • Allergies
    • Arthritis
    • Atrial fibrillation
    • Breast Cancer
    • Cancer
    • Crohn's Disease
    • Depression
    • Diabetes
    • DVT
    • Eczema
    • Eye Health
    • Heart Disease
    • HIV & AIDS
    • Lung Disease
    • Lupus
    • Mental Health
    • Multiple Sclerosis
    • Migraine
    • Pain Management
    • Psoriasis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sexual Conditions
    • Skin Problems
    • Sleep Disorders
    • Ulcerative Colitis
    • View All
  • Drugs & Supplements
    Drugs & Supplements
    • Drugs
    • Supplements
    • Pill Identifier
    • Interaction Checker
    • Pet Medications
  • Well-Being
    Well-Being
    • Aging Well
    • Baby
    • Birth Control
    • Children's Health
    • Diet & Weight Management
    • Fitness & Exercise
    • Food & Recipes
    • Health & Balance
    • Healthy Beauty
    • Men's Health
    • Parenting
    • Pet Health
    • Pregnancy
    • Sex & Relationships
    • Teen Health
    • Women's Health
  • Symptom Checker
  • Find a Doctor
  • More
    More
    • News
    • Blogs
    • Podcasts
    • Webinars
    • Newsletters
    • WebMD Surveys
    • WebMD Magazine
    • Best Hospitals
    • Support Groups
Log In
Content independently created by WebMD and supported by our partners.Learn More
  • Lung Cancer
  • Understanding EGFR Mutations in Non-Small-Cell Lung Cancer

How EGFR-Positive Lung Cancer Is Treated

Next
Article

Therapies and Treatments to Consider

Some non-small-cell lung cancers (NSCLC) have changes in a gene called EGFR. If your NSCLC has these mutations, your doctor likely will recommend treatment with targeted therapies that block EGFR. Learn what you should know about your treatment options and outlook.

Explore More
Infographic

Which Demographics Are More at Risk?

Who’s most at risk for getting EGFR-positive lung cancer? Learn which factors increase your chances.

Article

Exploring Clinical Trials

You’ll have more treatment options for EGFR-positive non-small-cell lung cancer (NSCLC) now than ever before. But doctors are still testing new treatments and combinations in clinical trials. Find out if a clinical trial may be an option for you.

Article

EGFR Mutations Defined

What are epidermal growth factor receptor (EGFR) mutations? Learn more about their biology, formation, and impact on lung cancer.

Video

What is EGFR-Positive Lung Cancer?

This subtype occurs in 10% to 15% of cases and is more common in people who have never smoked.

See More on Lung Cancer From WebMD

Go Now

  • Policies

    • Privacy Policy
    • Cookie Policy
    • Editorial Policy
    • Advertising Policy
    • Correction Policy
    • Terms of Use

  • About

    • Contact Us
    • Careers
    • Newsletter
    • WebMD App
    • Corporate
    • Site Map

  • For Advertisers

    • Advertise with Us
    • Market Research
  • TRUSTe
  • TAG Registered Seal
  • Adchoices

© 2005 - 2025 WebMD LLC, an Internet Brands company. All rights reserved. WebMD does not provide medical advice, diagnosis or treatment. See additional information.

Logo for WebMD